Companies › AZTR

AZITRA INC (AZTR)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001701478 · EDGAR filings · Updated 2026-07-15

AZITRA INC (AZTR) has reported institutional ownership of 3.3%, with 7 institutional managers holding positions valued at $126.5K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Latest updates

• 2026-07-15 — Current report (8-K) filed
• 2026-06-25 — SCHEDULE 13G filed
• 2026-06-24 — SCHEDULE 13D filed
• 2026-06-22 — SCHEDULE 13G filed
• 2026-06-18 — Insider transaction reported (Form 4)
• 2026-06-17 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, AZITRA INC has 7 institutional holders and institutional ownership of 3.3%.

Insider activity

Insiders reported 0 transactions (0 buys, 0 sells) across 0 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

Dermata Therapeutics Inc (DRMA) · Indaptus Therapeutics Inc (INDP) · Sunshine Biopharma Inc (SBFM) · ZOMEDICA CORP COM (ZOMDF) · Alzamend Neuro Inc (ALZN) · Bio Green Med Solution Inc (BGMS)